| Literature DB >> 30104798 |
Caroline Bollars1, Take Naseri2, Robert Thomsen2, Cherian Varghese3, Kristine Sørensen4, Nanne de Vries1, Ree Meertens1.
Abstract
PROBLEM: Samoa has been struggling to address the burden of noncommunicable diseases at the health system, community and individual levels. APPROACH: The World Health Organization (WHO) package of essential noncommunicable disease interventions for primary health care in low-resource settings was adopted in seven villages throughout Samoa in 2015. The National Steering Committee Members designed and implemented a screening process, and local facilitators and health-care workers collected health and lifestyle data. The WHO/International Society of Hypertension risk assessment was used on villagers older than 40 years to identify people at high risk of noncommunicable disease. LOCALEntities:
Mesh:
Year: 2018 PMID: 30104798 PMCID: PMC6083394 DOI: 10.2471/BLT.17.203695
Source DB: PubMed Journal: Bull World Health Organ ISSN: 0042-9686 Impact factor: 9.408
Health status of the population screened as part of the Fa’a Samoa package, Samoa, 2015
| Characteristics | No. of people/denominator (%) | ||
|---|---|---|---|
| Male | Female | Total | |
| Total population | 2136 | 1996 | 4132 |
| Total population > 18 years | 1119 | 1115 | 2234 |
| 18–29 | 339/1119 (30.29) | 335/1115 (30.04) | 674/2234 (30.17) |
| 30–39 | 213/1119 (19.03) | 234/1115 (20.99) | 447/2234 (20.01) |
| 40–49 | 248/1119 (22.16) | 210/1115 (18.83) | 458/2234 (20.50) |
| 50–59 | 157/1119 (14.03) | 146/1115 (13.09) | 303/2234 (13.56) |
| 60–69 | 98/1119 (8.76) | 121/1115 (10.85) | 219/2234 (9.80) |
| ≥ 70 | 64/1119 (5.72) | 69/1115 (6.19) | 133/2234 (5.95) |
| CVD-related symptomsa | 215/1110 (19.37) | 226/1107 (20.42) | 441/2217 (19.89) |
| TIA-related symptomsb | 231/1111 (20.79) | 264/1106 (23.87) | 495/2217 (22.33) |
| Diabetes-related symptomsc | 199/1105 (18.01) | 232/1101 (21.07) | 431/2206 (19.54) |
| Current smoker: smoked tobacco in last 12 months? | 500/1109 (45.09) | 167/1107 (15.09) | 667/2216 (30.1) |
| Alcohol abuse: binge drinking, excessive weekly intake | 456/1105 (41.27) | 74/1102 (6.72) | 530/2207 (24.01) |
| Physical inactivity: less than 30 minutes of exercise 3 times a week | 606/1097 (55.24) | 614/1101 (55.77) | 1220/2198 (55.51) |
| Systolic blood pressure ≥ 140 mmHg | 277/732 (37.84) | 234/831 (28.16) | 511/1563 (32.69) |
| BMI, kg/m2 | |||
| < 18.5 | 41/719 (5.70) | 61/809 (7.54) | 102/1528 (6.68) |
| 18.5–24.9 | 148/719 (20.58) | 90/809 (11.12) | 238/1528 (15.58) |
| 25–29.9 | 211/719 (29.35) | 157/809 (19.41) | 368/1528 (24.08) |
| 30–34.9 | 170/719 (23.64) | 187/809 (23.11) | 357/1528 (23.36) |
| ≥ 35 | 149/719 (20.72) | 314/809 (38.81) | 463/1528 (30.30) |
| Random blood glucose ≥ 11.1mmol/L | 36/723 (4.98) | 72/827 (8.71) | 108/1550 (6.97) |
| Total cholesterol, mmol/L | |||
| < 6.2 | 256/290 (88.28) | 274/378 (72.49) | 530/668 (79.34) |
| 6.2–7.99 | 22/290 (7.59) | 79/378 (20.90) | 101/668 (15.12) |
| ≥ 8 | 12/290 (4.14) | 25/378 (6.61) | 37/668 (5.54) |
| HDL cholesterol < 1 mmol/L (male), < 1.3 mmol/L (female) | 169/281 (60.14) | 231/369 (62.6) | 400/650 (61.54) |
| WHO/ISH CVD risk assessment | |||
| < 10% | 285/374 (76.2) | 353/432 (81.71) | 638/806 (79.16) |
| 10–19.9% | 46/374 (12.3) | 40/432 (9.26) | 86/806 (10.67) |
| 20–29.9% | 15/374 (4.01) | 13/432 (3.01) | 28/806 (3.47) |
| 30–39.9% | 12/374 (3.21) | 7/432 (1.62) | 19/806 (2.36) |
| ≥ 40% | 16/374 (4.28) | 19/432 (4.4) | 35/806 (4.34) |
BMI: body mass index; CVD: cardiovascular disease; HDL: high-density lipoproteins; ISH: International Society of Hypertension; TIA: transient ischaemic attack; WHO: World Health Organization.
a Symptoms are chest pain, tightness and/or breathlessness, likely to be worsened by exercise.
b Symptoms, which may be permanent or transient, are left- or right-sided weakness of limbs or face, difficulty speaking or periods of resolving blindness.
c Symptoms include constant thirst/drinking/passing urine, frequent bacterial infection (urinary tract, chest and skin), tiredness, blurred vision and foot ulcers.
Notes: Differences between total numbers of participants and numbers for which clinical measurements are available are due to missing data and the limited numbers of workers at the primary health-care level.